| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.615 | 11.636 | 21.644 | 34.491 | 41.016 | 35.775 |
| Total Income - EUR | - | - | - | - | 3.615 | 11.636 | 21.644 | 35.370 | 41.734 | 36.146 |
| Total Expenses - EUR | - | - | - | - | 849 | 1.875 | 4.964 | 7.392 | 22.499 | 19.542 |
| Gross Profit/Loss - EUR | - | - | - | - | 2.766 | 9.761 | 16.680 | 27.978 | 19.235 | 16.604 |
| Net Profit/Loss - EUR | - | - | - | - | 2.658 | 9.429 | 16.109 | 27.182 | 18.833 | 15.552 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Drperiohealth S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 3.041 | 3.845 | 1.843 | 211 |
| Current Assets | - | - | - | - | 2.812 | 12.291 | 13.436 | 24.903 | 28.174 | 46.355 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 2.285 | 8.633 | 11.792 | 19.348 | 23.056 | 32.352 |
| Cash | - | - | - | - | 527 | 3.657 | 1.643 | 5.555 | 5.119 | 14.003 |
| Shareholders Funds | - | - | - | - | 2.700 | 12.078 | 16.157 | 27.231 | 28.393 | 43.786 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 112 | 213 | 319 | 437 | 1.266 | 2.779 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 1.080 | 359 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Drperiohealth S.r.l.